426 related articles for article (PubMed ID: 24323901)
1. Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.
Touil Y; Igoudjil W; Corvaisier M; Dessein AF; Vandomme J; Monté D; Stechly L; Skrypek N; Langlois C; Grard G; Millet G; Leteurtre E; Dumont P; Truant S; Pruvot FR; Hebbar M; Fan F; Ellis LM; Formstecher P; Van Seuningen I; Gespach C; Polakowska R; Huet G
Clin Cancer Res; 2014 Feb; 20(4):837-46. PubMed ID: 24323901
[TBL] [Abstract][Full Text] [Related]
2. Regulation of cellular quiescence by YAP/TAZ and Cyclin E1 in colon cancer cells: Implication in chemoresistance and cancer relapse.
Corvaisier M; Bauzone M; Corfiotti F; Renaud F; El Amrani M; Monté D; Truant S; Leteurtre E; Formstecher P; Van Seuningen I; Gespach C; Huet G
Oncotarget; 2016 Aug; 7(35):56699-56712. PubMed ID: 27527859
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil chemotherapy of gastric cancer generates residual cells with properties of cancer stem cells.
Xu ZY; Tang JN; Xie HX; Du YA; Huang L; Yu PF; Cheng XD
Int J Biol Sci; 2015; 11(3):284-94. PubMed ID: 25678847
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of GSK3B bypass drug resistance of p53-null colon carcinomas by enabling necroptosis in response to chemotherapy.
Grassilli E; Narloch R; Federzoni E; Ianzano L; Pisano F; Giovannoni R; Romano G; Masiero L; Leone BE; Bonin S; Donada M; Stanta G; Helin K; Lavitrano M
Clin Cancer Res; 2013 Jul; 19(14):3820-31. PubMed ID: 23729362
[TBL] [Abstract][Full Text] [Related]
5. Microbial metabolite restricts 5-fluorouracil-resistant colonic tumor progression by sensitizing drug transporters via regulation of FOXO3-FOXM1 axis.
Ghosh S; Singh R; Vanwinkle ZM; Guo H; Vemula PK; Goel A; Haribabu B; Jala VR
Theranostics; 2022; 12(12):5574-5595. PubMed ID: 35910798
[TBL] [Abstract][Full Text] [Related]
6. Conditioned media from human macrophages of M1 phenotype attenuate the cytotoxic effect of 5‑fluorouracil on the HT‑29 colon cancer cell line.
Hedbrant A; Erlandsson A; Delbro D; Wijkander J
Int J Oncol; 2015 Jan; 46(1):37-46. PubMed ID: 25310018
[TBL] [Abstract][Full Text] [Related]
7. 5-fluorouracil resistant colon cancer cells are addicted to OXPHOS to survive and enhance stem-like traits.
Denise C; Paoli P; Calvani M; Taddei ML; Giannoni E; Kopetz S; Kazmi SM; Pia MM; Pettazzoni P; Sacco E; Caselli A; Vanoni M; Landriscina M; Cirri P; Chiarugi P
Oncotarget; 2015 Dec; 6(39):41706-21. PubMed ID: 26527315
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between YAP and RAR-RXR Drives Expression of Stemness Genes to Promote 5-FU Resistance and Self-Renewal in Colorectal Cancer Cells.
Bauzone M; Souidi M; Dessein AF; Wisztorski M; Vincent A; Gimeno JP; Monté D; Van Seuningen I; Gespach C; Huet G
Mol Cancer Res; 2021 Apr; 19(4):612-622. PubMed ID: 33472949
[TBL] [Abstract][Full Text] [Related]
9. Beta-Hydroxybutyrate Promotes Proliferation, Migration and Stemness in a Subpopulation of 5FU Treated SW480 Cells: Evidence for Metabolic Plasticity in Colon Cancer.
Shakery A; Pourvali K; Ghorbani A; Fereidani SS; Zand H
Asian Pac J Cancer Prev; 2018 Nov; 19(11):3287-3294. PubMed ID: 30486639
[TBL] [Abstract][Full Text] [Related]
10. The Level of
Przybyla T; Wesserling M; Sakowicz-Burkiewicz M; Maciejewska I; Pawelczyk T
Saudi J Gastroenterol; 2018; 24(1):37-45. PubMed ID: 29451183
[TBL] [Abstract][Full Text] [Related]
11. Functional significance of Hippo/YAP signaling for drug resistance in colorectal cancer.
Song R; Gu D; Zhang L; Zhang X; Yu B; Liu B; Xie J
Mol Carcinog; 2018 Nov; 57(11):1608-1615. PubMed ID: 30074279
[TBL] [Abstract][Full Text] [Related]
12. Canonical Wnt Pathway Is Involved in Chemoresistance and Cell Cycle Arrest Induction in Colon Cancer Cell Line Spheroids.
Moreno-Londoño AP; Castañeda-Patlán MC; Sarabia-Sánchez MA; Macías-Silva M; Robles-Flores M
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982333
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of acquired 5FU resistance and strategy for overcoming 5FU resistance focusing on 5FU metabolism in colon cancer cell lines.
Suetsugu T; Mori R; Futamura M; Fukada M; Tanaka H; Yasufuku I; Sato Y; Iwata Y; Imai T; Imai H; Tanaka Y; Okumura N; Matsuhashi N; Takahashi T; Yoshida K
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649846
[TBL] [Abstract][Full Text] [Related]
14. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
15. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.
Yaghoubi A; Asgharzadeh F; Movaqar A; Ghazvini K; Hassanian SM; Avan A; Khazaei M; Soleimanpour S
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2851-2865. PubMed ID: 34117917
[TBL] [Abstract][Full Text] [Related]
16. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon.
Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J
BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258
[TBL] [Abstract][Full Text] [Related]
17. c-myc/p53 interaction determines sensitivity of human colon carcinoma cells to 5-fluorouracil in vitro and in vivo.
Arango D; Corner GA; Wadler S; Catalano PJ; Augenlicht LH
Cancer Res; 2001 Jun; 61(12):4910-5. PubMed ID: 11406570
[TBL] [Abstract][Full Text] [Related]
18. The role of levamisole in the adjuvant treatment of stage III colon cancer patients: a randomized trial of 5-fluorouracil and levamisole versus 5-fluorouracil alone.
Cascinu S; Catalano V; Piga A; Mattioli R; Marcellini M; Pancotti A; Bascioni R; Torresi U; Silva RR; Pieroni V; Giorgi F; Catalano G; Cellerino R
Cancer Invest; 2003; 21(5):701-7. PubMed ID: 14628428
[TBL] [Abstract][Full Text] [Related]
19. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
[TBL] [Abstract][Full Text] [Related]
20. Early-stage colon cancer with high MALAT1 expression is associated with the 5-Fluorouracil resistance and future metastasis.
Ak Aksoy S; Tunca B; Erçelik M; Tezcan G; Ozturk E; Cecener G; Ugras N; Yilmazlar T; Yerci O
Mol Biol Rep; 2022 Dec; 49(12):11243-11253. PubMed ID: 35794508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
